Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 41% ± 25% | |
GABAergic neuron | 10 studies | 45% ± 25% | |
oligodendrocyte precursor cell | 10 studies | 28% ± 9% | |
interneuron | 6 studies | 51% ± 18% | |
neuron | 4 studies | 32% ± 8% | |
granule cell | 4 studies | 35% ± 5% | |
GABAergic interneuron | 3 studies | 41% ± 3% | |
Mueller cell | 3 studies | 50% ± 29% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 36% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 476.90 | 2604 / 2642 | 48% | 1.93 | 338 / 705 |
skin | 47% | 27.70 | 849 / 1809 | 0% | 0.01 | 2 / 472 |
breast | 22% | 18.81 | 101 / 459 | 1% | 0.02 | 8 / 1118 |
adipose | 22% | 15.63 | 268 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 3% | 1.59 | 7 / 258 | 19% | 0.41 | 43 / 230 |
ovary | 0% | 0 | 0 / 180 | 19% | 0.46 | 82 / 430 |
peripheral blood | 15% | 23.00 | 142 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.17 | 3 / 29 |
esophagus | 5% | 2.79 | 78 / 1445 | 3% | 0.09 | 6 / 183 |
muscle | 7% | 7.59 | 59 / 803 | 0% | 0 | 0 / 0 |
bladder | 5% | 1.52 | 1 / 21 | 3% | 0.06 | 13 / 504 |
thymus | 6% | 2.26 | 37 / 653 | 1% | 0.02 | 6 / 605 |
liver | 0% | 0 | 0 / 226 | 6% | 0.23 | 24 / 406 |
intestine | 4% | 1.77 | 42 / 966 | 1% | 0.03 | 7 / 527 |
stomach | 1% | 0.21 | 2 / 359 | 2% | 0.05 | 7 / 286 |
lung | 0% | 0.19 | 2 / 578 | 2% | 0.04 | 18 / 1155 |
uterus | 1% | 0.60 | 2 / 170 | 0% | 0.01 | 1 / 459 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.04 | 11 / 901 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.02 | 1 / 178 |
prostate | 0% | 0.14 | 1 / 245 | 0% | 0 | 0 / 502 |
heart | 0% | 0.13 | 3 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.03 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007040 | Biological process | lysosome organization |
GO_0032588 | Cellular component | trans-Golgi network membrane |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0031901 | Cellular component | early endosome membrane |
GO_0005768 | Cellular component | endosome |
GO_0030136 | Cellular component | clathrin-coated vesicle |
GO_0080025 | Molecular function | phosphatidylinositol-3,5-bisphosphate binding |
GO_1902936 | Molecular function | phosphatidylinositol bisphosphate binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CLVS1 |
Protein name | Clavesin 1 Clavesin-1 (Cellular retinaldehyde-binding protein-like) (Retinaldehyde-binding protein 1-like 1) (clathrin vesicle-associated Sec14 protein 1) |
Synonyms | MGC34646 CRALBPL RLBP1L1 hCG_1643170 |
Description | FUNCTION: Required for normal morphology of late endosomes and/or lysosomes in neurons (By similarity). Binds phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). . |
Accessions | ENST00000519846.5 [Q8IUQ0-1] ENST00000325897.5 [Q8IUQ0-1] ENST00000522621.1 Q8IUQ0 E5RK22 ENST00000520712.1 E5RI68 ENST00000523868.2 G3V122 ENST00000518592.5 A0A1D5RMS6 |